VALUATE HEALTH CONSULTANCY Trademark

Trademark Overview

On Friday, May 3, 2019, a trademark application was filed for VALUATE HEALTH CONSULTANCY with the United States Patent and Trademark Office. The USPTO has given the VALUATE HEALTH CONSULTANCY trademark a serial number of 88414827. The federal status of this trademark filing is REGISTERED as of Tuesday, April 27, 2021. This trademark is owned by Entrée Health LLC. The VALUATE HEALTH CONSULTANCY trademark is filed in the Insurance & Financial Services and Education & Entertainment Services categories with the following description:

Providing educational services in the nature of training, seminars and workshop in the field of market access for pharmaceutical and biotech products, managed health care markets and the prescribing of pharmaceuticals

Strategic financial consulting services in the field of market access for pharmaceutical and biotech products, managed health care markets and the prescribing of pharmaceuticals; Financial analysis in the field of market access for pharmaceutical and biotech products, managed health care markets and the prescribing of pharmaceuticals
valuate health consultancy

General Information

Serial Number88414827
Word MarkVALUATE HEALTH CONSULTANCY
Filing DateFriday, May 3, 2019
Status700 - REGISTERED
Status DateTuesday, April 27, 2021
Registration Number6337004
Registration DateTuesday, April 27, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding educational services in the nature of training, seminars and workshop in the field of market access for pharmaceutical and biotech products, managed health care markets and the prescribing of pharmaceuticals
Goods and ServicesStrategic financial consulting services in the field of market access for pharmaceutical and biotech products, managed health care markets and the prescribing of pharmaceuticals; Financial analysis in the field of market access for pharmaceutical and biotech products, managed health care markets and the prescribing of pharmaceuticals
NOT AVAILABLE"CONSULTANCY"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, January 16, 2020
Primary Code036
First Use Anywhere DateSunday, June 30, 2019
First Use In Commerce DateSunday, June 30, 2019
International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, May 20, 2019
Primary Code041
First Use Anywhere DateSunday, June 30, 2019
First Use In Commerce DateSunday, June 30, 2019

Trademark Owner History

Party NameEntrée Health LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10014
US
Party NameEntrée Health LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10014
US

Trademark Events

Event DateEvent Description
Tuesday, May 7, 2019NEW APPLICATION ENTERED
Monday, May 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 17, 2019ASSIGNED TO EXAMINER
Thursday, July 25, 2019NON-FINAL ACTION WRITTEN
Thursday, July 25, 2019NON-FINAL ACTION E-MAILED
Thursday, July 25, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 1, 2020FINAL REFUSAL WRITTEN
Saturday, February 1, 2020FINAL REFUSAL E-MAILED
Saturday, February 1, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, February 7, 2020ASSIGNED TO EXAMINER
Tuesday, August 18, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, August 18, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, October 13, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 19, 2021ASSIGNED TO PETITION STAFF
Thursday, January 21, 2021INCOMPLETE PETITION NOTICE MAILED
Wednesday, January 27, 2021TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Monday, February 22, 2021PETITION GRANTED - RESPONSE RECEIVED
Monday, February 22, 2021ASSIGNED TO LIE
Monday, February 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 22, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, March 3, 2021TEAS AMENDMENT OF USE RECEIVED
Thursday, March 4, 2021USE AMENDMENT FILED
Thursday, March 4, 2021AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, March 17, 2021USE AMENDMENT ACCEPTED
Wednesday, March 17, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, March 18, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, March 23, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 27, 2021REGISTERED-SUPPLEMENTAL REGISTER
Monday, April 27, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

consultancy health valuate managed products pharmaceutical care pharmaceuticals prescribing markets access biotech